STOCK PRICE

[anonymous]

Before complexity can be managed, it has to be created. I think our leadership has done an outstanding job in creating a truly complex and messy scenario for the company.

We will be less than $1B market cap very soon..

Brilliant, well said! This company cannot even get the simple things right.
Bedminster is a place for big pharma rejects!
Markie Mark needs to go!

 

[anonymous]

What's up with the stock price. Is MNK buying it up? It seems to be defying gravity .

 

[anonymous]

Doesn’t make any sense. Will go back down. This is a fraud. OIG, payer issues etc will not turn around.

 

[anonymous]

Stocks headed to the moon !

 

[anonymous]

Thanks HO. I feel better now. Keep spewing your BS. Sinking ship and you know it!

 

[anonymous]

Thanks HO. I feel better now. Keep spewing your BS. Sinking ship and you know it!

Being captain of a sinking ship pays better than being on the dock with no ship.

 

[anonymous]

Being captain of a sinking ship pays better than being on the dock with no ship.

Welcome to the Titanic! Enjoy the ride!

 

[anonymous]

wow our stock is cooking with gas. Up 33% in 10 days!!!!!!!
We are back baby.
We have made back all our loses to last month. Only 30 more months of loses and $115 to catch up on

 

[anonymous]

Great time to short! Payer coverage for Acthar will only continue to get worst. No way out of this one. Game over!!!

 

[anonymous]

Is the company buying back stock? I can't believe after all the bad press that anyone with half a brain would buy this. The shorts have got to be licking their chops.

 

[anonymous]

They have to be. No other way the stock is moving up so much. Again another piss poor decision. We are in debt up to our eyeballs. Piled on even more debt for products that didn’t get approved. Acthar sells are declining, margins are shrinking even faster and the buy back stock versus pay debt down and actually invest in the underlying businesses. MNK will have a Valeant like fire sale inside of the next 2 years. If they lose Medicaid coverage for Acthar in February it will be even sooner.

 

[anonymous]

it would be a fire sale because none of our products have a clear
Value with inomax patent loss, acthar coverage issues, oformev
29 months before generics and so on. Ok, some value in pipeline for 3 products until we try to commercialize them.
Bonobyi and peds constipaton. Etc to come

 

[anonymous]

You shithead shorts and bears should go kill yourself.

 

[anonymous]

MNK has a flawed and completely unsustainable business model and that is some how the short sellers issue. I don’t think you understand how the market works.

Besides that most shorts have cashed in and moved on. Not much meat left on this dead carcass of a company. 90% of the market value is gone.

 

[anonymous]

2Q18 earnings out on 8/7. I'll be enjoying the show and raking in the dough...mostly from shorts of course.

 

[anonymous]

41% float shorted 33.5M shares. Price going to $60's.
Enjoying the show!

 

[anonymous]

Q2 isn’t where your issue will MNK will show. 60 minutes and subsequent decking in Naive referrals will have a larger impact in Q3 and CNN effects in Q3 and Q4. There are better places to park your money. Far too much risk and not enough upside.

 

[anonymous]

MNK is the place to park your money. It's going $60's.

 

[anonymous]

Stock down on news of Praxair, looking forward to more competitors. Acthar, Therakos etc. The ship is going like a cheap whore, but then again that's what MNK is!

 

[anonymous]

Stock down on news of Praxair, looking forward to more competitors. Acthar, Therakos etc. The ship is going like a cheap whore, but then again that's what MNK is!

Where has the jackass claiming the stock was going to 60’s been. He’s almost as funny as the ALL CAPS JACKASS!!!